Durham, NC, United States of America

Mohamad Mikati

This inventor holds 2 USPTO granted patents. Top assignee: Duke University. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohamad Mikati. Retrieved from https://idiyas.com/inventor/mohamad-mikati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mohamad Mikati: Innovator in ATPase-Mediated Disease Treatment

Introduction

Mohamad Mikati is a prominent inventor based in Durham, NC (US). He has made significant contributions to the field of medical research, particularly in the treatment of ATPase-mediated diseases. With a total of 2 patents, his work is paving the way for innovative therapeutic approaches.

Latest Patents

Mikati's latest patents include "Methods of Treating ATPase-Mediated Diseases with a Nucleic Acid Encoding ATP1A3 and a Neuron-Specific Promoter" and "Compositions Comprising Nucleic Acid Molecules and Methods of Treating ATPase-Mediated Diseases." These patents provide nucleic acid expression cassettes, vectors, compositions, and methods aimed at treating ATPase-mediated diseases in subjects.

Career Highlights

Mikati is affiliated with Duke University, where he conducts his research and development. His work is characterized by a strong focus on innovative solutions to complex medical challenges.

Collaborations

Mikati collaborates with notable colleagues, including Aravind Asokan and Arsen Hunanyan, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Mohamad Mikati's contributions to the field of ATPase-mediated disease treatment exemplify the importance of innovation in medical research. His patents and collaborations reflect a commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…